Development of SPQC Biosensor for Streptococcus pneumoniae Detection Based on IscB Nuclease Recognition

YiFan Sun1, YuSheng Liao1, Fengjiao He1

  • 1State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, P.R. China.

Analytical Chemistry
|August 22, 2025
PubMed

Insights

A new biosensor rapidly detects Streptococcus pneumoniae (S. pneumoniae) using the IscB protein. This advancement offers a sensitive and selective method for identifying this deadly bacterium, crucial for public health.

Area of Science:

  • Microbiology
  • Biotechnology
  • Biosensor Technology

Background:

  • Streptococcus pneumoniae is a leading cause of infectious disease mortality, particularly in children.
  • Rapid and accurate detection of S. pneumoniae is critical for effective public health interventions.
  • The IscB protein, an RNA-guided DNA endonuclease, shows promise for detecting specific DNA sequences and mismatches.

Purpose of the Study:

  • To develop a novel biosensor for the rapid and sensitive detection of Streptococcus pneumoniae.
  • To utilize the IscB protein's specific recognition capabilities for pathogen identification.
  • To integrate rolling circle amplification and urease-catalyzed urea hydrolysis for enhanced detection.

Main Methods:

  • Development of a novel series piezoelectric quartz crystal (SPQC) sensor.
  • Specific recognition of S. pneumoniae using the IscB protein.
  • Integration of rolling circle amplification and urease-catalyzed urea hydrolysis for signal amplification.

Main Results:

  • The SPQC biosensor achieved rapid detection of S. pneumoniae nucleic acids within 3 hours.
  • The sensor demonstrated a broad detection range from 10^3 to 10^8 CFU/mL.
  • A low detection limit of 550 CFU/mL and excellent selectivity against common bacteria were achieved.

Conclusions:

  • The developed IscB-based SPQC biosensor provides a rapid, sensitive, and selective method for S. pneumoniae detection.
  • This platform shows significant potential for clinical diagnostic applications in managing S. pneumoniae infections.
  • The integration of novel recognition and amplification strategies enhances biosensing capabilities for bacterial pathogens.